Definium Therapeutics is a late-stage clinical biopharmaceutical company focused on developing accessible treatments for psychiatric disorders using psychedelics. Their lead product candidate, lysergide tartrate, targets generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Their early-stage pipeline includes DT402 for autism spectrum disorder. The company aims to address the underlying causes of psychiatric and neurological disorders and improve mental health care. Headquartered in New York and trading on Nasdaq (DFTX), Definium Therapeutics is seeking a Director, Product Communications to lead strategic communications for their late-stage pipeline, including Phase 3 data readouts, regulatory filings, and launch readiness. This role is crucial for shaping the company's narrative, managing corporate and product reputation, and preparing the market for a potential first-in-class launch. The position reports to the VP of Corporate Communications and collaborates with various cross-functional teams to develop clear, compliant, and impactful messaging across multiple channels to reach key stakeholders.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director